DEVICES SOLUTIONS RESOURCES ABOUT CONTACT Press InnoVero and Tasso Partner to Provide Non-Invasive, Athlete-Centric Solutions for Anti-Doping Testing InnoVero LLC, maker of the innovative SAFESystem™ sample collection kit currently revolutionizing global anti-doping practices, today announced a partnership with Tasso, Inc. to become the exclusive worldwide distributor for Tasso blood collection devices for the anti-doping marketplace. The partnership will accelerate global efforts to expand consistent non-invasive anti-doping testing. Read More → Oct 19, 2021 Tasso-M20 Device Earns CE Mark Certification for At-Home, Self-Sampling Blood Collection Tasso Inc., a pioneer in clinical-grade, at-home, self-sampling blood collection, today announced that its Tasso-M20 device has received a CE (Conformité Européene) Mark certification and has successfully fulfilled all of the European Union’s performance, safety, and relevant product requirements. With this marking, Tasso is now able to provide pharmaceutical companies, leading medical institutions, and government health centers across the European Union and other CE Mark geographies with a best-in-class diagnostic experience for their patients. Read More → May 19, 2021 Tasso Secures $17 Million Series A Financing to Scale Production of At-Home Blood Collection Systems and Capitalize on Growing Demand for Remote Diagnostic Testing Tasso Inc., a pioneer in clinical-grade, at-home, self-sampling blood collection, today announced it has completed an oversubscribed $17 million Series A financing round. The company will use the proceeds to scale manufacturing and operations to meet the increased demand for its line of innovative Tasso OnDemand devices, which enable people to collect their own blood using a virtually painless process from anywhere at any time. These fast and easy-to-use products are being adopted by leading academic medical institutions, government agencies, comprehensive cancer centers, and pharmaceutical organizations around the world. Read More → Jul 22, 2020 Tasso Raises $6.1M to Bring Effortless Blood Collection into the Home Tasso, Inc. has completed a $6.1 million round of financing led by Vertical Venture Partners (“VVP”), with participation from Techstars and Cedars-Sinai. This new funding will help Tasso scale its first product Tasso OnDemand, which enables at-home self-collection of blood samples, and grow the team to support significant commercial interest. Read More → Mar 5, 2019 Tasso and partners receive $4.25M to develop a universal surveillance platform for infectious disease outbreaks Tasso, Inc. (Tasso), Ceres Nanosciences (Ceres), George Mason University (Mason), and the United States Army Medical Research Institute of Infectious Diseases (USAMRIID) today announced the commencement of an $11.7 million program, funded by the Defense Threat Reduction Agency (DTRA), to develop a reliable, safe, and simple universal surveillance platform for infectious disease outbreaks. Read More → Sep 28, 2017 Tasso simplifies blood draws, awarded $3M expansion Tasso, Inc., a medtech start-up developing the HemoLink™, a small disposable device to simplify blood sampling, has secured an additional $2.9M in grant funding to advance its HemoLink technology with its development partner GenTegra LLC. Read More → Apr 7, 2015 Tasso, Inc. simplifies blood sampling, secures $2.3M Tasso, Inc., a medtech start-up developing a wearable blood draw device, has secured $2.3M in grant funding for its HemoLink­™ technology. Read More → Feb 3, 2014 TERMS OF USE PRIVACY POLICY Tasso, Inc. 1631 15th Ave W, Suite 105 Seattle, WA 98119 United States